is celebrating its 40th anniversary! We hope you enjoyed the spring cover that
kicked off our celebratory spirit. In case you’ve missed it, the cover showed
several editions of past JLMEs—from
its humble beginnings as a newsletter to the multi-page journal you read today.
Our first issue of the year, “The Graying of America: Challenges and
Controversies,” guest by Robert M. Sade, is now available online. Please click here to read the latest articles.
Now we are working on the summer issue, “Pharmaceutical Firms and the
Right to Health,” guest edited by Thana Campos and Thomas Pogge. This
symposium is a result of a two-day conference in 2010 at the University
of Sao Paulo (Brazil) and its Centre for the Study of Violence (NEV/USP). The distinguished cohort of
authors examine global health inequities and pharmaceutical policy matters. The
right to health remains a much discussed topic, and the authors employ several
perspectives in discussing the role that government and pharmaceutical
companies play in providing access to medicines. Brazil, for example, has
become a leader in global health because of both its domestic policy and
international influence. Stating in their Constitution that “health is a
right of all and a duty of the State,” the Brazilian government is also leading
efforts for global collaborations with the United Nations and World Trade
Organization. The authors also discuss pharmaceutical patents and the
availability of generic medicines, the new international organization called the
Health Impact Fund, and pharmaceutical companies’ responsibilities to protect
health and human rights—among many other topics. The issues are not new, but
the authors provide innovative solutions that reflect the changing scope of
global health and pharmaceutical policy.
Thank you for reading JLME and celebrating its anniversary
all year with us! If you would like to share your thoughts on an article or
have a suggestion for us, please feel free to contact us. As
always, we value your continued readership of JLME. We look forward to hearing from you.